2024-11-25 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Report

**1. Performance Relative to S&P 500 (VOO):**

Eli Lilly and Co. (LLY) is a global pharmaceutical company that researches, develops, manufactures, and markets pharmaceutical products and medical devices.

The cumulative return for LLY is 587.41%, significantly outperforming the S&P 500's cumulative return of 127.58%.  The difference is 459.83%, placing it at the 68.58th percentile of its historical performance relative to the S&P 500 based on the provided data.  This indicates strong historical outperformance.

The provided Alpha and Beta analysis shows consistently high CAGR (Compound Annual Growth Rate) exceeding the S&P 500 implied return,  with a Beta generally around 0.7, suggesting less volatility than the overall market.  However, Maximum Drawdown (MDD) increased significantly in recent years, indicating higher risk.


**2. Recent Price Movement:**

* **Closing Price:** $747.79 (Last Market: $746.05)
* **5-Day Moving Average:** $741.61
* **20-Day Moving Average:** $799.84
* **60-Day Moving Average:** $873.92

The stock is currently trading below its 5, 20, and 60-day moving averages, suggesting a downward trend.  The relatively small difference between the closing price and the last market price suggests minimal price fluctuation on the last trading day.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 37.12 - Suggests the stock is in oversold territory, potentially indicating a bounce.
* **PPO (Price Oscillator):** -0.56 -  A negative value suggests bearish momentum.
* **Delta_Previous_Relative_Divergence:** -20.19 - Shows a recent decline in relative strength against the S&P 500.
* **Expected Return:** 169.79% - This represents a significant potential long-term (2+ years) outperformance relative to the S&P 500 if a long-term investment strategy is adopted. The last market price of $746.05 is not significantly higher than the closing price to suggest a sudden surge.


**4. Recent Earnings and Outlook:**

The provided earnings data shows some volatility.  While recent quarters show strong revenue, EPS has fluctuated significantly. The October 30th, 2024 earnings report is available but the expected earnings were not provided.  Further analysis of the earnings report and associated press releases is needed to understand these fluctuations and the future outlook.  A comparison with analysts' estimates is crucial for a complete picture.

**5. Financial Information:**

* **Revenue and Profitability:** Consistently high revenue and profit margins over the past year indicate strong financial performance.  The slight dip in Q3 2023 revenue is notable.

* **Capital and Profitability:** ROE (Return on Equity) has fluctuated, with a significant drop in Q3 2023, followed by a rebound in Q2 2024, suggesting volatility in profitability.  Further investigation is required to ascertain the underlying causes.

**6. News and Recent Issues:**

* **Recent Earnings News:**  (This section requires access to recent news sources like Shacknews and financial news websites to provide an analysis of the most recent earnings announcements and market reaction.  Include details on analyst ratings and any significant news impacting the stock price).

* **Market Outlook/Analyst Opinions:**  (A summary of recent market outlooks and analyst opinions from sources like FINBOLD is needed here. This should include information on price targets and overall sentiment towards the stock.)

**7. Overall Analysis:**

LLY has demonstrated strong historical outperformance against the S&P 500. However, recent price action suggests a downward trend, while technical indicators present a mixed picture.  While the high expected return is enticing, the recent volatility in earnings and ROE warrants caution.  A thorough analysis of the latest earnings reports, analyst opinions, and any major news impacting the company is crucial before making any investment decision. The high MDD in recent years suggests higher risk.  Further due diligence is necessary.


**8. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investment decisions should be based on thorough research and consideration of individual risk tolerance.
